Stay updated on RMC-6236 in RAS Mutant Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the RMC-6236 in RAS Mutant Solid Tumors Clinical Trial page.

Latest updates to the RMC-6236 in RAS Mutant Solid Tumors Clinical Trial page
- Check5 days agoChange DetectedA new site revision tag (v3.6.2) has been introduced, replacing the previous revision (v3.6.0). This indicates a minor platform update without altering the study details or primary content.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedAdded new help/navigation items (Check who can join, Find Contact Information, How to Read a Study Record, Common Questions, How to Join a Study) and updated the Intervention/Treatment section label, along with a site Revision: v3.6.0.SummaryDifference0.4%

- Check27 days agoChange DetectedThe page’s footer revision tag was updated to v3.5.5, signaling a minor page revision. This change typically reflects small content or formatting updates rather than alterations to study data.SummaryDifference0.0%

- Check41 days agoChange DetectedThe locations section has been expanded to add new recruitment sites, bringing the total to 21 locations across multiple states. New sites include Virginia Mason Medical Center in Seattle, WA, along with several other participating centers.SummaryDifference1%

- Check48 days agoChange DetectedA new NEJM publication citation for Daraxonrasib in previously treated advanced RAS-mutant pancreatic cancer has been added, and the page revision tag was updated from v3.5.3 to v3.5.4.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page now displays Revision: v3.5.3, replacing the previous Revision: v3.5.2. This reflects a minor version update to the page.SummaryDifference0.0%

Stay in the know with updates to RMC-6236 in RAS Mutant Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RMC-6236 in RAS Mutant Solid Tumors Clinical Trial page.